Recombinant Shigella boydii serotype 4 ATP synthase subunit c (atpE) is a bioengineered protein derived from the ATP synthase enzyme of Shigella boydii, a Gram-negative bacterium causing dysentery. The protein is expressed in E. coli as a full-length (1–79 amino acids) construct with an N-terminal His-tag for purification and stability. Its UniProt identifier is Q31UN7, and it is commercially available as a lyophilized powder with >90% purity .
| Aspect | Recommendation |
|---|---|
| Storage | -20°C/-80°C in aliquots; avoid repeated freeze-thaw cycles |
| Reconstitution | Dissolve in deionized water (0.1–1.0 mg/mL); add 50% glycerol for long-term storage |
| Working Aliquots | Store at 4°C for ≤1 week |
Adapted from Creative Biomart protocols .
The atpE gene in S. boydii serotype 4 is part of the chromosomal ATP synthase operon. Notably, S. boydii genomes exhibit high diversity compared to other Shigella species, with serotype 4 strains like Sb227 (strain 227) showing distinct genetic features . This diversity may influence ATP synthase function and resistance to environmental stressors .
While recombinant ATP synthase subunits are available for other Shigella serotypes (e.g., S. boydii serotype 18 ), serotype 4’s atpE is unique due to its sequence and genomic integration. For example:
KEGG: sbo:SBO_3750
ATP synthase subunit c (atpE) is a critical component of the F0 sector of the F-type ATP synthase in Shigella boydii. This membrane-embedded protein forms an oligomeric ring structure that facilitates proton translocation across the bacterial membrane during ATP synthesis. The protein typically consists of 79-82 amino acids with a highly hydrophobic profile, containing predominantly alpha-helical secondary structures that span the membrane .
In bacterial physiology, atpE plays an essential role in energy metabolism by converting the proton gradient across the membrane into the mechanical energy needed for ATP synthesis. This function makes it indispensable for bacterial survival and growth, particularly under energy-limited conditions. Mutations in atpE can significantly impact bacterial bioenergetics and potentially affect virulence and antibiotic susceptibility.
Optimal expression of recombinant Shigella boydii atpE in E. coli requires careful consideration of several factors:
Expression System Components:
Vector selection: pET vectors with T7 promoters are frequently used for membrane proteins like atpE due to their tight regulation and high expression potential
E. coli strain: C41(DE3) or C43(DE3) strains are preferred for membrane proteins as they can accommodate the potentially toxic effects of membrane protein overexpression
Fusion tags: N-terminal His-tags (as seen in the serotype 18 construct) facilitate purification while minimizing interference with membrane insertion
Optimized Expression Conditions:
Temperature: Lower temperatures (16-25°C) often improve proper folding of membrane proteins
Induction: Low concentrations of IPTG (0.1-0.5 mM) with longer expression times (16-24 hours)
Media supplements: Addition of glucose (0.5-1%) to suppress basal expression and potential toxicity
Aeration: Moderate aeration to balance growth and protein expression
The expression protocol should include careful monitoring of bacterial growth post-induction, as membrane protein overexpression can significantly impact cell viability.
Purification of recombinant atpE presents significant challenges due to its hydrophobic nature and membrane association. The following multi-step approach is recommended:
Membrane Isolation:
Cell disruption via French press or sonication in a buffer containing 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 5 mM MgCl₂, and protease inhibitors
Differential centrifugation to separate membrane fractions
Solubilization of membranes using detergents
Detergent Selection:
Mild detergents such as n-dodecyl-β-D-maltoside (DDM) or lauryl maltose neopentyl glycol (LMNG) at 1-2% concentration
Incubation at 4°C for 1-2 hours with gentle agitation
Affinity Chromatography:
Immobilized metal affinity chromatography (IMAC) using the N-terminal His-tag
Wash buffer containing reduced detergent concentration (0.05-0.1%)
Elution with imidazole gradient (50-300 mM)
Size Exclusion Chromatography:
Further purification by size exclusion chromatography
Buffer containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 0.03-0.05% detergent
Protein Quality Assessment:
Maintaining protein stability during and after purification requires careful buffer optimization and proper storage conditions.
When encountering challenges with recombinant atpE expression and solubility, researchers should consider the following troubleshooting strategies:
| Challenge | Potential Causes | Recommended Solutions |
|---|---|---|
| Low expression yield | - Protein toxicity - Codon bias - Promoter leakage | - Use C41/C43(DE3) strains - Optimize codon usage - Add glucose to suppress basal expression - Lower growth temperature to 16-20°C |
| Poor solubility | - Improper membrane insertion - Inclusion body formation - Inadequate detergent | - Optimize detergent type and concentration - Try detergent screening - Consider fusion partners like MBP - Test refolding protocols if necessary |
| Protein degradation | - Protease activity - Instability in chosen buffer | - Increase protease inhibitor concentration - Optimize buffer conditions (pH, salt) - Use freshly prepared buffers - Process samples at 4°C |
| Aggregation during purification | - Detergent concentration too low - Harsh elution conditions | - Maintain critical micelle concentration - Use gradient elution - Add glycerol (5-10%) as stabilizer |
| Loss during concentration | - Adherence to concentration devices - Precipitation | - Pre-treat concentrators with dilute detergent - Concentrate in smaller volume increments - Monitor protein state during concentration |
For long-term storage, addition of 6% trehalose in Tris/PBS-based buffer at pH 8.0 has been effective for maintaining stability, with storage at -20°C/-80°C after aliquoting to avoid freeze-thaw cycles .
While ATP synthase subunit c is primarily known for its role in energy metabolism, emerging research suggests connections between bacterial bioenergetics and pathogenesis:
Potential Pathogenesis Mechanisms:
Energy production to support various virulence factor expression
Maintenance of membrane potential which may influence secretion systems
Adaptation to varying energy environments within the host
The structural features of atpE make it a potential antibiotic target. The oligomeric ring formed by multiple atpE subunits contains a conserved aspartate residue critical for proton translocation. This site has been targeted by antibiotics such as diarylquinolines, which bind to and inhibit mycobacterial ATP synthase. Similar approaches could potentially be developed for Shigella.
Research into the structural and functional relationships of atpE could inform novel antimicrobial development strategies specifically targeting Shigella infections, which would be especially valuable given the rising antibiotic resistance in Shigella species.
Understanding atpE interactions within the ATP synthase complex requires sophisticated methodological approaches:
Crosslinking Studies:
Chemical crosslinking combined with mass spectrometry to identify interaction points
Photo-activatable amino acid analogs for precise interaction mapping
Zero-length crosslinkers to identify direct protein-protein contacts
Biophysical Methods:
Surface plasmon resonance (SPR) to determine binding kinetics
Microscale thermophoresis for quantifying molecular interactions
Isothermal titration calorimetry (ITC) for thermodynamic profiling
Structural Biology Approaches:
Cryo-electron microscopy of the entire ATP synthase complex
Solid-state NMR for membrane-embedded interactions
X-ray crystallography of subcomplexes or the complete assembly
Functional Assays:
ATP synthesis/hydrolysis assays to assess the impact of mutations
Proton translocation measurements using fluorescent probes
Reconstitution experiments in liposomes or nanodiscs
Genetic Approaches:
Site-directed mutagenesis of interaction interfaces
Suppressor mutation analysis to identify compensatory changes
CRISPR-Cas9 genome editing to create variant proteins
These approaches provide complementary information that, when integrated, can yield comprehensive insights into how atpE contributes to ATP synthase function and potentially influences Shigella pathogenicity.
Strategic modifications to recombinant atpE can significantly impact its functional properties, enabling various experimental applications:
Key Structural Modifications:
Site-Directed Mutagenesis:
Mutation of the conserved proton-binding aspartate residue to assess proton translocation mechanisms
Alteration of hydrophobic residues to examine membrane insertion and stability
Introduction of cysteine residues for site-specific labeling or crosslinking
Fusion Proteins and Tags:
Domain Swapping:
Exchange of segments between different bacterial species to assess species-specific functions
Creation of chimeric proteins to map functional domains
Functional Consequences of Modifications:
When designing modifications, researchers should consider the highly conserved nature of atpE and its critical role in bacterial survival. Validation experiments comparing modified atpE with wild-type protein are essential to ensure that observed effects are due to the specific modification rather than general structural disruption.
Comprehensive quality assessment of recombinant atpE requires multiple complementary analytical techniques:
SDS-PAGE Analysis:
Mass Spectrometry Approaches:
MALDI-TOF or ESI-MS for intact protein mass determination
Peptide mass fingerprinting after proteolytic digestion
Top-down proteomics for complete sequence verification
Chromatographic Methods:
Size exclusion chromatography to assess oligomeric state and aggregation
Reverse-phase HPLC for purity assessment
Ion exchange chromatography to detect charge variants
Spectroscopic Techniques:
Circular dichroism to verify alpha-helical secondary structure
Fluorescence spectroscopy to examine tertiary structure
FTIR for assessment of secondary structure components
Functional Assays:
ATPase activity measurements when incorporated into ATP synthase complex
Proton translocation assays in reconstituted systems
Thermal shift assays to assess protein stability
The combination of multiple analytical techniques provides comprehensive characterization of recombinant atpE preparations, ensuring both structural integrity and functional competence.
Verifying the functional activity of purified recombinant atpE requires specialized assays that assess its ability to function within the ATP synthase complex:
Reconstitution Experiments:
Incorporation of purified atpE into proteoliposomes
Co-reconstitution with other ATP synthase subunits to form functional complexes
Measurement of ATP synthesis driven by artificial proton gradients
Proton Translocation Assays:
Fluorescent pH indicators to monitor proton movement
Potential-sensitive dyes to assess membrane potential changes
Radioisotope-based assays for precise quantification
Binding Studies:
Surface plasmon resonance to measure interactions with other ATP synthase subunits
Isothermal titration calorimetry for thermodynamic characterization
Native mass spectrometry to observe complex formation
Structural Integrity Assessment:
Oligomerization analysis using native PAGE or analytical ultracentrifugation
Electron microscopy to visualize ring formation
Atomic force microscopy for nanoscale structural analysis
Inhibitor Binding Studies:
Measuring specific binding of known ATP synthase inhibitors
Competition assays with labeled ligands
Thermal shift assays in the presence of inhibitors
When interpreting results from these assays, it's important to consider that atpE functions as part of a complex, and its activity is interdependent with other ATP synthase components. Comparing results with those obtained using native ATP synthase provides important contextual information for interpreting recombinant protein function.
The potential applications of recombinant atpE extend beyond basic research into practical diagnostic and therapeutic developments:
Vaccine Development Applications:
Recombinant atpE could serve as a carrier protein for antigenic epitopes
While not a primary virulence factor, conserved membrane proteins like atpE may provide cross-protection against multiple serotypes
Combination with other antigens in multicomponent vaccines could enhance protection
Diagnostic Applications:
Development of serotype-specific antibodies against variable regions of atpE
Creation of highly sensitive PCR primers targeting serotype-specific regions
Potential component in multiplexed diagnostic assays for differentiation of Shigella species and serotypes
Technical Considerations:
For vaccine applications, careful removal of all contaminating endotoxin is critical
For diagnostics, high-purity preparations are essential to avoid cross-reactivity
Expression systems need to be validated for diagnostic-grade or clinical-grade production
While not directly implicated in virulence like some other Shigella proteins (e.g., the StcE zinc metalloprotease found in atypical Shigella boydii 13) , the essential nature and conservation of atpE make it an interesting target for both diagnostic and therapeutic applications.
Several cutting-edge technologies are poised to revolutionize our understanding of atpE biology:
These emerging technologies will provide unprecedented insights into the fundamental biology of atpE and potentially reveal new approaches for targeting ATP synthase in antimicrobial development.